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1. Introduction 
The first report on tissue engineering (TE) dates back to the book of Genesis where “…the 
Lord God sent a deep sleep on the man, and took one of the bones from his side while he 
was sleeping, joining up the flesh against its place” ( Genesis ). Interestingly and perhaps 
inadvertently, the importance of bone as a scaffold in the process of tissue engineering was 
acknowledged even in the scriptures. The ultimate goal of TE is to regenerate and replace 
structural and functional deficits of tissue, beyond its natural healing capacity. For that 
purpose, external regenerative resources including scaffolds, cells and growth/trophic 
factors (GF) either alone or in combination are employed (Place et al., 2009; Tanner, 2010;, 
Rokn et al., 2011). The general strategy of TE uses undifferentiated cells seeded within a 
scaffold which defines the geometry of the replacement tissues, and provides environmental 
cues to promote the development of new tissues (Zuk, 2008;,Place et al., 2009; Binderman et 
al., 2011.). It is now well understood that the cell-scaffold interaction is a crucial part of TE 
and should mimic the interaction between cell surface receptors and the extracellular matrix 
(ECM). The ECM, composed of various macromolecules such as proteoglycans, collagens, 
laminins, fibronectins and sequestered growth factors, is responsible for regulating cellular 
functions including survival, adhesion, proliferation, migration, differentiation, and matrix 
deposition (Binderman et al., 2011). Furthermore, it is now widely accepted that bone matrix 
and its cellular environment constitute one of the best known niche of adult stem cells both 
for hematopoiesis and mesenchymal tissues (Ferrer, et al., 2010). Given the complexity of 
living tissue, current approach for TE does not support attempts to recreate tissue ex vivo. 
Instead, one should develop synthetic materials that will establish key interactions with cells 
and unlock the body’s innate powers of organization and self-repair (Place et al., 2009; 
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Binderman et al., 2011). This principal of using the body as a “bioreactor” guides our 
development strategy for TE of bone (Stevens, et al., 2005).  
Autografts and allogenic grafts are routinely used in the clinic. Nevertheless, the morbidity 
associated with harvesting of autografts and their limited availability, and the inferior 
mechanical properties of allogenic grafts have spurred the search for the optimal artificial 
bone substitute material. Numerous artificial bone grafts are commercially available. These 
include macroporous bioactive ceramic granules made from calcium sulphate, tricalcium 
phosphate (ß-TCP), synthetic hydroxyapatite (HA), and biphasic calcium phosphate (a 
mixture of TCP and HA) (Hing, 2004; Jones et al., 2010). Although widely used, calcium 
sulphate and to a lesser extent TCP, dissolve very rapidly, often resulting in a new defect. 
HA on the other hand degrades very slowly, thus impeding the apposition of new bone. In 
fact, osteoprogenitor cells in conjunction with scaffold and osteogenic factors were used to 
create bone tissue both in vitro and in vivo (Binderman,et al., 2011). These engineered bone 
grafts have been shown to posses the capacity for osteogenesis, but also for osteoconduction 
and even bioactivity. Ideally, the engineered bone should form a structural and functional 
connection with the host bone, also termed as physical connectivity. Unfortunately, 
vascularization of engineered bone tissue remains a major obstacle in achieving a clinically 
sized bone grafts.  
While the physical and chemical requirements for scaffold composition and design for TE of 
bone are well defined, our ability to produce them is still limited. Scaffold should be 
manufactured from bioactive material that allows attachment of cells to its surface and their 
transformation to functional osteoblasts. Its design should contain macropores, 200-500 µm 
across, to allow in-growth of bone tissue and blood vessels, and apposition of mineralized 
bone matrix directly on the surface of the material (Hing et al.,2004; Zuk, 2008). On the other 
hand, biocompatible scaffold are less desirable since they allow formation of bone 
arbitrarily. Additionally, scaffold should be constructed from degradable material thus 
enabling the newly formed tissue to gradually replace it. Finally, scaffolds should maintain 
their mechanical stability and allow loading of the newly formed composite tissue. To the 
best of our knowledge, as of yet no such material has been reported to have all these 
characteristics.  
This paper focuses on a specific rodent model which provides a remarkable tool for the 
study of TE of bone in a non-bone ectopic site. A comparative analysis of commercially 
available scaffolds is presented. To complement the analysis, clinical biopsies of grafted 
sinuses are also shown. 
2. Animal studies  
Dark Agouti (DA) inbred rats were used to study the bioactive properties of four bone graft 
materials (BGM), ranging from weak biocompatability to high bioactivity, namely (a) 
Cerabone, inorganic bovine bone treated, manufactured by aap Implantate AG, Dieburg, 
Germany, (b) Bio-Oss, mineral of bovine bone, manufactured by Geistlich Pharma AG, 
Wolhusen, Germany, (c) NanoBone, synthetic silicium rich hydroxyapatite, manufactured 
by Artoss GMBH, Rostock,Germany, and (d) ReproBone, synthetic tricalcium phosphate 
and hydroxyapatite (40:60, %) mineral, manufactured by Ceramisys, Sheffield, England; all 
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in particulate form. Our model is highly reproducible and has two major advantages: (a) 
bone is formed under the osteogenic environment of bone marrow and BGM, in a 
subcutaneos site; this way it excludes the direct effects of host bone tissue surroundings, and 
(b) new bone is formed within 3 weeks after implantation ( Yaffe et al.,2003; Bahar et al., 
2003; Bahar et al., 2010; Binderman et al., 2011). In brief, the BGM is mixed with freshly 
harvested femural marrow (3:1, v/v) of 6-8 weeks old DA rats. The mixture is immediately 
implanted into a subcutaneous space prepared by blunt dissection in the thoracic region of 
other native DA rat (Figure 1). Three weeks later, animals were euthanized and the 
subcutaneous implant was harvested for microradiography and histology. 
 
Fig. 1. Surgical implantation of BGM mixed with fresh marrow at the thoracic site of DA rats. 
Three weeks later the BGM implant was removed for microradiography (white arrows, x3). 
Our histological evaluation included the following aspects: (i) the ability of the BGM to 
recruit osteogenic cells onto its surface, triggering bone deposition directly on the BGM 
structure, (ii) the ability of new bone to allow ingrowth of blood vessels and formation of 
new marrow, (iii) the recruitment of osteoclasts to resorb BGM. In this manner, a 
comparative analysis of commercially available BGM's was performed. Previously, we have 
shown histologically that fresh marrow interacting with demineralized bone matrix (DBM) 
of DA rats produced an ossicle consisting of a thin cortical bone surrounding numerous 
trabecullii which occupied new active marrow tissue (Yaffe et al.,2003; Bahar et al., 2003; 
Bahar et al., 2010; Binderman, 2011). Here, we compared the interaction of BGM's with fresh 
marrow that leads to osteogenesis in the thoracic subcutaneous site of DA rats. Moreover, 
we evaluated the reaction between the same BGM's in the osteogenic environment of the 
human maxillary sinus, on growth and deposition of bone.  
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In the present study, microradiography of all implanted BGM's revealed a similar view of 
composite including BGM material and mineralized new bone (Fig. 1). In contrast, 
histological analysis demonstrated differences between the biocompatible and the 
bioactive BGMs as demonstrated in the following figures. Deposition of cell-rich new 
bone can be seen in close proximity to the particles of processed bovine bone matrix of 
both Cerabone (Figs. 2a and 2b) and Bio-Oss (Figs. 2c and 2d).  
 
Fig. 2. Histological sections of Cerabone (a and b) and Bio-Oss (c and d), 3 weeks after 
implantation in DA rats. Black arrows show tight interface of Bio-Oss with bone matrix. 
While most of the Cerabone surfaces were separated from the newly formed bone by layers 
of connective tissue including blood vessels, fibroblasts and poor matrix, some surfaces of 
the Bio-Oss BGM showed an intimate relationship with the new deposited bone, creating a 
cement line at their interface (Fig. 2d, arrow). Neither Cerabone nor Bio-Oss demonstrated 
active bone marrow or osteoclasts, suggesting poor resorptive properties. Although both 
Bio-Oss and Cerabone are composed of the mineral portion of bovine bone (no collagen was 
expected to be present) we found residual collagen in demineralized histological sections of 
Bio-Oss but not of Cerabone. The possibility exists that bone mineral may protect the 
organic material during the process of Bio-Oss preparation. Whether the improved 
biocompatability of Bio-Oss in comparison to that of Cerabone, could be attributed to the 
presence of bone matrix should be further investigated (Rokn et al.,2011). Nevertheless, 
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these findings suggest that Bio-Oss and Cerabone are biocompatible rather than bioactive 
and that they have poor resorbable qualities. 
NanoBone which is composed of hydroxyapatite enriched by silicium (24%) is considered to 
be bioactive (Gotz et al., 2008, Jones, et al.,2010). In our DA rat system, deposition of bone 
was seen in intimate association and engulfing the surfaces of the Nanobone particles, 
indicating high bioactivity (Fig. 3).  
 
Fig. 3. Histological sections of NanoBone BGM 3 weeks after implantation. 3a shows 
connectivity of interfaces between bone and NanoBone; m=marrow spaces, including 
vessels and cells. 3b and 3c shows the bone interfaces with NanoBone by cement line (Black 
arrows). B= bone, N= NanoBone BGM,. 3d shows several osteoclasts (OSC) , indicated by 
arrows on NanoBone surfaces.  
Active bone marrow and many blood vessels surrounded by new bone were also seen in 
these histological sections. A structure of bone-BGM-bone continuity and tight connectivity 
of mineralized matrices that occured can provide an optimal BGM for implant anchorage 
and function. In the demineralized histological sections an organic residue basic material 
was present where the NanoBone particles reside. Because NanoBone is strictly mineral, it 
seems that the organic material is composed of blood proteins that are absorbed by this 
BGM. It was already suggested that blood proteins are absorbed mainly by silicium, thus 
allowing attachment of osteognic cells onto them (Jones et al.,2010). Surprisingly, in the case 
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of ReproBone that is composed of 40% beta-tricalcium phosphate (ß-TCP) and 60% 
hydroxyapatite (HA) bone was deposited directly on its surfaces, in a similar fashion 
observed in NanoBone bioactive BGM. 
 
Fig. 4. Histological sections of ReproBone, 3 weeks after implantation in DA rats. 4a and 4b, 
show connectivity of bone and ReproBone througout the section. Newly formed bone is filling 
many of the macropores. 4c emphasizes the bone ReproBone interface (arrow), the highly 
active marrow and blood vessls, m=marrow, repro=ReproBone residual organic material. 4d 
shows very active osteoblasts linning new bone interfacing the BGM (white arrow). 
Our observation that organic basic residue is seen in demineralized histological sections of 
Reprobone, similar to that seen in NanoBone sections, may suggest that also here 
glycoproteins from the blood are strongly absorbed throughout the Reprobone material. 
Furthermore, Reprobone but not NanoBone allowed blood vessels ingrowth into 
macropores, and new bone-surrounded marrow cells to be deposited on the pores (Fig. 4, 
arrow). This ingrowth into macropores is reminiscent of Howship lacunae in normal bone, 
and was not seen in other BGM's tested in this study. The presence of osteoclasts on the 
surfaces of the NanoBone (Figure 3d, osc) and Reprobone indicate active remodeling and 
therefore high degree of bioactivity. These results support the use of Reprobone since it 
fulfills the criteria for an excellent BGM, namely, highly bioactive, allows blood vessels and 
bone ingrowth into its pores, contains active marrow and undergoes active remodeling 
(Figure 4). 
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3. Clinical studies  
To complement the animal data we present histological sections of BGM-grafted sinus 
biopsies taken from patients who underwent sinus lift procedures. All surgical procedures 
and biopsies were performed by Dr. Philipe Russe. In brief, under local anesthesia full 
thickness flap was elevated to access the anterior wall of the maxillary sinus. Using 
piezosugery (piezosurge III by Mectron) a bony lid was detached and the Schneiderian 
membrane was elevated. BGM was then placed into the sinus and rehydrated with the 
plated-rich-fibrin (PRF) exsudate and metronidazole (Fig. 5a). The bony window was placed 
back, covered with PRF membranes and the flap was sutured (Fig. 5c). 4-6 months later, 
bone core biopsies were taken at the implant site using a trephine (Dentsply Frios 51-4091) 
with external and internal diameters of 3.1 and 2 mm, respectively (Figure 5d). Biopsies 
were then pushed out gently of the trephine, and taken for histology.  
 
Fig. 5. (a) BGM it seen in sinus immediately after filling (b) Conen beam of sinus filled with 
BGM.  (c) Opening of Sinus is covered by bone and PRF, before suturing back the mucosa. (d) 
The bone core biopsy before implant insertion (4-6 month after grafting sinus with BGM). 
The osteogenic potential of the Schneiderian membrane has been previously described 
(Srouji, et al., 2010; Srouji, et al., 2009; Kim, et al., 2009). Histological sections from sinus 
grafted with Cerabone (Fig. 6c and 6d) reveal that this although considered biocompatible, 
the Cerabone is separated from the newly formed bone by a layers of soft connective tissue.  
www.intechopen.com
 
Bone Regeneration 
 
90
 
Fig. 6. Histological sections of biopsies of Bio-Oss (a and b) and Cerabone (c and d). Here we 
can clearly see that the interface between Bio-Oss and new bone is tight in many surfaces 
(black arrow in 6b), while Cerabone is separated from bone by soft connective tissue (white 
arrow in 6c). 
Thus, the biopsy from the grafted Cerabone showed islands of grafted BGM and islands of 
mineralized bone, surrounded by soft connective tissue. In contrast, histological sections 
from biopsies of sinus grafted with Bio-Oss demonstrated new osteocyte-rich bone 
surrounding the Bio-Oss particles. The particles were separated from bone by few layers of 
connective tissue, cells and matrix and many of the Bio-Oss surfaces interphased with bone, 
creating a cement line of physical bond between bone and Bio-Oss (Fig. 6d, arrow). Bone 
could not be seen in any of the pores of this BGM. In the marrow spaces fat cells and sparse 
fibrous tissue, and no osteoclasts could be seen on the surfaces of Bio-Oss. Still, since it is 
made of cortical bone, clinicians feel that its bio-mechanical qualities are such that implants 
are well anchored and stabilized in the bone and Bio-Oss composite. These findings suggest 
that Bio-Oss is highly biocompatible and to some extent bioactive, in agreement with our 
animal observations. Biopsies taken from sinuses grafted with NanoBone or ReproBone 
presented an integrated mosaic of these BGM's and bone. A physical connectivity of BGM 
and bone was seen throughout the sections of both NanoBone and ReproBone. The marrow 
spaces were usually rich in blood cells and blood vessels, and both osteoclastic activity and 
matrix-producing active osteoblasts were present (Fig. 7). 
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Fig. 7. Histological sections of biopsies 4-6 month after grafting in sinuses of humans. 7a and 
7b the BGM is NanoBone (NB). 7c and 7d sections from ReproBone (RP).  
In both NB and RP sections connectivity of bone and BGM could be seen. Bone marrow (m) 
was viable and blood cells were dispersed. Macropores were filled with new bone ,blood 
vessel and marrow. Interestingly, bone ingrowth into large pores was seen mostly in 
Reprobone sections but not in those of NanoBone. These results are in accord with the animal 
data and demonstrate the uniqueness of Reprobone in attracting ingrowth of blood vessels 
and bone into many of macropores. Viable marrow was seen in both NanoBone and 
ReproBone biopsies, indicating active bone surfaces (Ferrer, et al., 2010). This group (Ferrer,et 
al.,2010) proposed that hematopoietic and mesenchymal cells in marrow are much dependent 
on active osteoblasts. It seems that both ReproBone and NanoBone support bone formation 
that active in producing viable marrow and is can also undergo remodeling by osteoclasts. The 
data presented demonstrate the resemblance of Cerabone, Bio-Oss, NanoBone and ReproBone 
characteristics in the DA rat model and in human grafted sinuses. 
4. Conclusions 
In this chapter we presented a remarkable animal model for tissue engineering of bone in a 
non-osseous site. This model allows for bone generation in a very efficient and reproducible 
manner. Furthermore, it provides an in vivo measuring tool for assessing the 
biocompatibility and bioactivity of BGM’s. Hydroxyapatite bone mineral (HA) and its 
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calcium phosphate derivatives that lack the organic components of bone are considered 
biocompatible BGM’s. They are routinely employed in bone grafting procedures to restore 
or fill bone defects. However, if structured to absorb serum components that can attract and 
bind active cells from their near environment, then these BGM’s will be converted into 
bioactive BGM's. Consequently, the attached cells are expected to express their osteogenic 
phenotype and deposit bone directly on BGM’s surfaces, and induce new, viable and active 
hematopoietic marrow in the new TE bone. Our animal studies and also clinical biopsies 
demonstrate that ReproBone is a highly bioactive BGM.  
Of interest is our observation that Reprobone when processed as a wet moldable product to 
be delivered through syringe (Reprobone Novo), inhibited osteogenesis in our DA rat model 
(Fig. 8c and Fig. 8d). Interestingly, another product named Bonit Matrix (DOT Gmbh, 
Rostock , Germany) that was shown to be bioactive in our model, but when processed for 
delivery by syringe (Ossa Nova), demonstrated only granulation tissue surrounding the 
particles but no bone formation (Fig. 8a and 8b). Furthermore, multi-nucleated giant cells 
were also seen (Fig. 8d). We assume that these (and other) products that are intended for 
syringe delivery have a smaller particle size of less than 50 m. Condensation of small 
particles may change their ability to interact with cells properly. 
 
Fig. 8. Histological sections of BGM's delivered by syringe including Ossa Nova (8a and 8b) 
and Repro-Novo (8c and 8d). Both were mixed with bone marrow and implanted in DA 
rats. See in both BGM's no bone was visible. 
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The process of bone engineering depends on the normal cascade of wound healing which 
begins with the inflammatory response. At the same time, the process requires an 
immediate interplay between the progenitor cells and the BGM surface. This reaction is 
followed by the recruitment, proliferation and differentiation of osteoprogenitor cells, 
synthesis of ECM proteins, and angiogenesis.  
We have recently demonstrated that as soon as 3-4 days after implantation of DBM and 
fresh marrow in DA rats, a significant upregulation of osteoblast and of angiogenic genetic 
profile was measured (Bahar, et al., 2007). These findings support our view that very early 
after grafting, accurate and tuned interactions between the unique surface of BGM and the 
extracellular and cellular environment are crucial in leading the pathway for de-novo 
engineering of bone.  
It is well accepted that continuity and connectivity of bone trabeculli is essential to the 
transmission of functional forces in our body. For example, in osteoporotic patients 
spontaneous fractures occur when trabecullii in long bones are resorbed and connectivity is 
disrupted. Consequently, forces are transmitted through alternative and vulnerable 
pathways that are unable to absorb them. We therefore propose that a clinician should use 
BGM's that produce physical connectivity with bone. If the mechanical properties, like 
strength and stiffness of the BGM are similar to that of bone, such connectivity of bone-BGM 
will provide an excellent biomaterial for implant function. Whether NanoBone or 
ReproBone physical properties are in the range of compact bone is plausible.  
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